Amorphous pharmaceutical solids: Preparation, characterization and stabilization

Advanced Drug Delivery Reviews

Volumn 48, Issue 1, 2001, Pages 27-42

  Yu, Lian ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Amorphous solid; Characterization of amorphous solid; Preparation of amorphous solid; Stabilization of amorphous solid

Indexed keywords

AMORPHOUS MATERIALS; CRYSTALS; PROTEINS; QUENCHING; SOLIDS; THERMODYNAMIC PROPERTIES;

SPRAY-DRYING;

DRUG PRODUCTS;

DRUG ADDITIVE; EXCIPIENT; GLASS; PEPTIDE; PROTEIN; SUCROSE; TREHALOSE;

ARTICLE; CRYSTALLIZATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; DRUG SYNTHESIS; PHASE TRANSITION; PRIORITY JOURNAL; SOLID STATE; TECHNIQUE; THERMODYNAMICS;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY; DRUG STABILITY; TECHNOLOGY, PHARMACEUTICAL; THERMODYNAMICS;

EID: 0035897584     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00098-9     Document Type: Article

References (119)

1. Craig D.Q.M., Royall P.G., Kett V.L., Hopton M.L. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int. J. Pharmaceut. 179:1999;179-207.
2. Hancock B.C., Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1997;1-12.
3. Kerè J., Srèiè S. Thermal analysis of glassy pharmaceuticals. Themochim. Acta. 248:1995;81-95.
4. Trelfall T.L. Analysis of organic polymorphs: a review. Analyst. 120:1995;2435-2460.
5. Brittain H.G. Polymorphism in Pharmaceutical Solids. 1999;Marcel Dekker, New York.
6. Yu L., Reutzel S.M., Stephenson G.A. Physical characterization of polymorphic drugs: an integrated characterization strategy. Pharm. Sci. Tech. Today. 1:1998;118-127.
7. Angell C.A. Formation of glasses from liquids and biopolymers. Science. 267:1995;1924-1935.
8. A broad recent interest in glasses and the glass transition has resulted in several special issues: J. Non-Crystalline Solids, 131-133(1991); Science 267(1995); ACS Symposium Series 676 (Supercooled liquids: advances and novel applications); and J. Phys. Chem. 103(1999) (dedicated to C. A. Angell).
9. A broad recent interest in glasses and the glass transition has resulted in several special issues: J. Non-Crystalline Solids, 131-133(1991); Science 267(1995); ACS Symposium Series 676 (Supercooled liquids: advances and novel applications); and J. Phys. Chem. 103(1999) (dedicated to C. A. Angell).
10. A broad recent interest in glasses and the glass transition has resulted in several special issues: J. Non-Crystalline Solids, 131-133(1991); Science 267(1995); ACS Symposium Series 676 (Supercooled liquids: advances and novel applications); and J. Phys. Chem. 103(1999) (dedicated to C. A. Angell).
11. A broad recent interest in glasses and the glass transition has resulted in several special issues: J. Non-Crystalline Solids, 131-133(1991); Science 267(1995); ACS Symposium Series 676 (Supercooled liquids: advances and novel applications); and J. Phys. Chem. 103(1999) (dedicated to C. A. Angell).
12. Ediger M.D., Angell C.A., Nagel S.R. Supercooled liquids and glasses. J. Phys. Chem. 100:1996;13200-13212.
13. Haleblian J., McCrone W. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58:1969;911-929.
14. Stillinger F.H., Weber T.A. Packing structures and transitions in liquids and solids. Science. 225:1984;983-989.
15. Pikal M. Freeze-drying of proteins: process, formulation and stability. Cleland L.J., Langer R. Formulation and Delivery of Proteins and Peptides. ACS Symposium Series 567 :1994;20-133 ACS, Washington, DC.
16. Carpenter J.F. Interactions of stabilizers with proteins during freezing and drying. Cleland L.J., Langer R. Formulation and delivery of proteins and peptides. ACS Symposium Series 567 :1994;134-147 ACS, Washington, DC.
17. Crowe J.H., Carpenter J.F., Crowe L.M. The role of vitrification in anhydrobiosis. Annu. Rev. Physiol. 60:1998;73-103.
18. Yu L., Reutzel-Edens S.M., Mitchell C.A. Crystallization and polymorphism of conformationally flexible molecules: problems, patterns, and strategies. Org. Proc. Res. and Dev. 4:2000;396-402.
19. Siniti M., Jabrane S., Letoffe J.M. Study of the respective binary phase diagrams of sorbitol with mannitol, maltitol and water. Thermochim. Acta. 325:1999;171-180.
20. Jeffrey G.A., Kim H.S. Conformations of the alditols. Carbohydr. Res. 14:1970;207-216.
21. Broadhead J., Rouan Edmond S.K., Rhodes C.T. The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. 18:1992;1169-1206.
22. Niven R.W. Delivery of biotherapeutics by inhalation aerosols. Pharm. Technol. 17:1993;72-82.
23. Yu L., Mishra D.S., Rigsbee D.R. Determination of the glass properties of D-mannitol using sorbitol as an impurity. J. Pharm. Sci. 87:1998;774-777.
24. Chiou W.L., Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60:1971;1281-1302.
25. Saleki-Gerhardt A., Stowell J.G., Byrn S.R., Zografi G. Hydration and dehydration of crystalline and amorphous forms of raffinose. J. Pharm. Sci. 84:1995;318-323.
26. Y. Li, J. Han, G.G.Z. Zhang, D.J.W. Grant, R. Suryanarayanan, In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine. Pharmaceutical Development and Technlogy (in press).
27. Johari G.P., Ram S., Astl G., Mayer E. Characterizing amorphous and microcrystalline solids by calorimetry. J. Non-Crystalline Solids. 116:1990;282-285.
28. Cassel B., Twombly B. Rapid DSC determination of polymer crystallinity. Am. Lab. Jan.(1998);24-27.
29. Pikal M.J., Lukes A.L., Lang J.E., Gaines K. Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability. J. Pharm. Sci. 67:1978;767-773.
30. Buckton G., Darcy P. Int. J. Pharmaceut. 179:1999;141-158.
31. Lavergne C., Lacabanne C. A review of thermally stimulated current. IEEE Electrical Insulation Magazine. 9:1993;5-21.
32. Venkatesh G.M., Barnett M.E., Owusu-Fordjour C., Galop M., Brown H.L. A comparative evaluation of techniques for detecting low levels the amorphous phase in crystalline pharmaceutical materials. AAPS, San Francisco :1998;. Poster.
33. Johari G.P., Goldstein M. Viscous liquids and the glass transition II secondary relaxation in glasses of rigid molecules. J. Chem. Phys. 53:1970;2372-2388.
34. Johari G.P. Effect of annealing on the secondary relaxations in glasses. J. Chem. Phys. 77:1982;4619-4626.
35. Fagegaltier N., Lamure A., Lacabanne C., Caron A., Mifsud H., Bauer M. Thermal analysis of amorphous phase in a pharmaceutical drug. J. Thermal Anal. 48:1997;459-464.
36. H. Tanaka, Two-order-parameter description of liquids. I. A general model of glass transition covering its strong and fragile limit (p. 3163-3174). II. Criteria for vitrification and predictions of our model (pp. 3175-3182). J. Chem. Phys. 111(1999) 3163-3174 and 3175-3182.
37. H. Tanaka, Two-order-parameter description of liquids. I. A general model of glass transition covering its strong and fragile limit (p. 3163-3174). II. Criteria for vitrification and predictions of our model (pp. 3175-3182). J. Chem. Phys. 111(1999) 3163-3174 and 3175-3182.
38. H. Tanaka, Two-order-parameter description of liquids. I. A general model of glass transition covering its strong and fragile limit (p. 3163-3174). II. Criteria for vitrification and predictions of our model (pp. 3175-3182). J. Chem. Phys. 111(1999) 3163-3174 and 3175-3182.
39. Kivelson D., Pereda J.-C., Luu K., Lee M., Sakai H., Ha A., Cohen I., Tarjus G. Facts and speculation concerning low-temperature polymorphism in glass formers. Fourkas J., Kivelson D., Mohanty U., Nelson K. Supercooled liquids: advances and novel applications. ACS Symposium Series 676 :1997;American Chemical Society, Washington, D.C.
40. Poole P.H., Grande T., Angell C.A., McMillan P.F. Polymorphic phase transitions in liquids and glasses. Science. 275:1997;322-323.
41. Westrum E.F., McCullough J.P. Thermodynamics of crystals. Fox D., Labes M.M., Weissberger A. Physical Chemistry of the Organic Solid State. 1963;Interscience Publishers, New York.
42. Christian J.W. The Theory of Transformations in Metals and Alloys. 1981;Pergamon, Oxford.
43. Adam G., Gibbs J.H. J. Chem. Phys. 43:1965;139-146.
44. Fukuoka E., Makita M., Nakamura Y. Glassy state of pharmaceuticals. V. Relaxation during cooling and heating of glass by differential scanning calorimetry. Chem. Pharm. Bull. (39):1991;2087-2090. See also previous papers in this series.
45. Hodge I.M. Enthalpy Relaxation and Recovery in Amorphous Materials. J. Non-Crystallilne Solids. 169:1994;211-266.
46. Reading M., Hahn B.K., Crowe B.S. Method and apparatus for modulated differential analysis, 6 July 1993, US Patent 5 224 775. See also P. S. Gill, S. R. Sauerbrunn, M. Reading, J. Thermal Anal. 40:1993;931.
47. Hill V.L., Craig Q.M.D., Feely L.C. Characterisation of spray-dried lactose using modulated differential calorimetry. Int. J. Pharmaceut. 161:1998;95-107.
48. Angell C.A., Sare J.M., Sare E. J. Glass transition temperatures for simple molecular liquids and their binary solutions. J. Phys. Chem. 82:1978;2622.
49. Kim H.S., Jeffrey G.A. Acta Cryst. B25:1969;2607.
50. Streitwieser A., Heathcock C.H. Introduction to Organic Chemistry. Second Edition :1981;Macmillan Publishing Co., Inc, New York.
51. The Merck Index. 10th Edition. Merck & Co., Inc.: Rahway, NJ, 1983.
52. Schmitt E.A., Law D., Zhang G.G.Z. Nucleation and crystallization kinetics of hydrated amorphous lactose above the glass transition temperature. J. Pharm. Sci. 88:1999;291-296.
53. Marwick T.C. An X-ray study of mannitol, dulcitol and mannose. Nature. 127:1931;11-12.
54. McCrea G.W. An X-ray study of mannitol. Nature. 127:1931;162-163.
55. Rye A., Sorum H. Crystalline modifications of d-mannitol. Acta Chem. Scand. 6:1952;1128-1129.
56. Berman H.M., Jeffrey G.A., Rosentein R.D. The crystal structures of the α' and β forms of d-mannitol. Acta Cryst. B24:1968;442-449.
57. Kim H.S., Jeffrey G.A., Rosenstein R.D. The crystal structure of the k form of d-mannitol. Acta Cryst. B24:1968;1449-1455.
58. Walter-Levy L. Sur les varietes crystallines du D-mannitol. C. R. Acad. Sci. Paris. 267:1968;1779-1782.
59. Debord B., Lefebvre C., Guyot-Hermann A.M., Hubert J., Bouche R., Guyot J.C. study of different crystalline forms of mannitol: comparative behaviour under compression. Drug Dev. Ind. Pharm. 13:1987;1533-1546.
60. Jones F.T., Lee K.S. The optical and crystallographic properties of three phases of mannitol. Microscope. 18:1970;279-285.
61. 13C-N.M.R. chemical shifts of carbohydrates in the solid state. The spectra of D-mannitol polymorphs and of DL-mannitol. Carbohydr. Res. 197:1990;41-52.
62. Pitkanen I., Perkkalainen P., Rautiainen H. Thermoanalytical studies of phases of D-mannitol. Thermochim. Acta. 214:1993;157-162.
63. Burger A., Henck J.-O., Hetz S., Rollinger J.M., Weissnicht A.A. Energy/temperature diagram and compression behavior of the polymorphs of mannitol. J. Pharm. Sci. 89:2000;457-468.
64. Yu L., Milton N., Groleau E.D., Mishra D.S., Vansickle R.E. Existence of a mannitol hydrate during freeze-drying and practical implications. J. Pharm. Sci. 88:1999;196-198.
65. Du Ross J.W. Modification of the crystalline structure of sorbitol and its effect on tableting characteristics. September(1984);Pharmaceutical Technology. 42-53.
66. Siniti M., Carre J., Bastide J.P., Letoffe J.M., Claudy P. The thermal behavior of hexitols. part 2. polymorphism of dulcitol. Thermochim. Acta. 224:1993;105-110.
67. Sussich F., Urbani R., Princivalle F., Cesaro A. Polymorphic amorphous and crystalline forms of trehalose. J. Am. Chem. Soc. 120:1998;7893-7899.
68. Kim A.I., Akers M.J., Nail S.L. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J. Pharm. Sci. 87:1998;931-935.
69. Cavatur R.K., Suryanarayanan R. Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry. Pharm. Res. 15:1998;194-199.
70. Kovalcik T., Guillory J.K. The stability of cyclophosphamide in lyophilized cakes. part I. mannitol, lactose, and sodium bicarbonate as excipients. J. Parenteral Sci. Tech. 42:1988;29-39.
71. Izutsu K., Yoshioka S., Terao T. Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. Chem. Pharm. Bull. 42:1994;5-8.
72. Jolley J. Photogr. Sci. Eng. 14:1970;167-177.
73. Andronis V., Zografi G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non-Crystalline Solids. 271:2000;236-248.
74. Willaims N.A., Lee Y., Polli G.P., Jennings T.A. The effect of cooling rate on solid phase transitions and associated vial breakage occurring in frozen mannitol solutions. J. Parenteral Sci. Tech. 40:1986;135-141.
75. Williams N.A., Dean T. Vial breakage by frozen mannitol solutions: correlation with thermal characteristics and effect of stereoisomerism, additives and vial configuration. J. Parenteral Sci. Tech. 45:1991;94-100.
76. Kelton K.F. Nucleation in silicate and metallic glasses. Int. J. Non-Equilibrium Proc. 11:1998;141-168.
77. Senapati H., Kadiyala R.K., Angell C.A. Single- and two-step calorimetric studies of crystallization kinetics in simple ionic glass-forming liquids. 1. Ca(NO3)2-KNO3 system. J. Phys. Chem. 95:1991;7050-7054.
78. Andronis V., Zografi G. Molecular mobility of supercooled amorphous indomethacin determined by dynamic mechanical analysis. Pharm. Res. 14:1997;410-414.
79. Correia N.T., Alvarez C., Ramos J.J.M., Descamps M. Molecular motions in molecular glasses as studied by thermally stimulated depolarization currents (TSDC). Chem. Phys. 252:2000;151-163.
80. Qi F., Schug K.U., Dupont S., Döβ A., Böhmer R., Sillescu H., Kolshorn H., Zimmerman H. Structural relaxation of the fragile glass-former propylene carbonate studied by nuclear magnetic resonance. J. Chem. Phys. 112:2000;9455-9462.
81. Moynihan C.T., Easteal A.J., Wilder J. Dependence of the glass transition temperature on heating and cooling rate. J. Phys. Chem. 78:1974;2673.
82. Moynihan C.T., Lee S.-K., Tatsumisago M., Minami T. Estimation of activation energies for structural relaxation and viscous flow from dta and dsc experiments. Thermochim. Acta. 280-281:1996;153-162.
83. Skoglund P., Fransson A. Thermochim. Acta. 276:1996;27-39.
84. Hohne G.W.H., et al. Thermochim. Acta. 221:1993;129-137.
85. Moynihan C.T. correlation between the width of the glass transition region and the temperature dependence of the viscosity of high-tg glasses. J. Am. Ceram. Soc. 76:1993;1081.
86. Bruning R., Sutton M. Fragility of glass-forming systems and the width of the glass transition. J. Non-Crystalline Solids. 205-207:1996;480-484.
87. Bustin O., Descamps M. Slow structural relaxations of glass-forming maltitol by modulated DSC calorimetry. J. Chem. Phys. 110:1999;10982-10992.
88. Mehl P.M. Calorimetric investigation of the glass transition and relaxation in 60:40 ethylene glycol:water. Part 1. Isothermal annealing experiments. Thermochim. Acta. 213:1993;177-197.
89. Mehl P.M. Determination of enthalpy relaxation times using traditional differential scanning calorimetry for glycerol and for propylene glycol. Thermochim. Acta. 272:1996;201-209.
90. Shamblin S.L., Zografi G. Enthalpy relaxation in binary amorphous mixtures containing sucrose. Pharm. Res. 15:1998;1828-1834.
91. Hancock B.C., Shamblin S.L., Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 12:1995;799-806.
92. Angell C.A. Relaxation in liquids, polymers and plastic crystals -strong/fragile patterns and problems. J. Non-Crystalline Solids. 131-133:1991;13.
93. Bohmer R., Ngai K.L., Angell C.A., Plazek D.J. Nonexponential relaxations in strong and fragile glass formers. J. Chem. Phys. 99:1993;4201-4209.
94. Green J.L., Fan J., Angell C.A. The protein-glass analogy: some insights from homopeptide comparisons. J. Phys. Chem. 98:1994;13780-13790.
95. Samouillan V., Lamure A., Lacabanne C. Dielectric relaxation of collagen and elastin in the dehydrated state. Chem. Phys. 255:2000;259-271.
96. Hodge I.M. J. Non-Crystalline Solids. 202:1996;164-172.
97. Richert R., Angell C.A. J. Chem. Phys. 108:1998;9016.
98. Green J.L., Ito K., Xu K., Angell C.A. Fragility in liquids and polymers: new, simple quantitations and interpretations. J. Phys. Chem. B. 103:1999;3991-3996.
99. Ito K., Moynihan C.T., Angell C.A. Thermodynamic determination of fragility in liquids and a fragile-to-strong liquid transition in water. Nature. 398:1999;492-495.
100. Hancock B.C., Dalton C.R., Pikal M.J., Shamblin S.L. A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials. Pharm. Res. 15:1998;762-767.
101. Olsen N.B. Scaling of beta-relaxation in the equilibrium liquid state of sorbitol. J. Non-Crystalline Solids. 235-237:1998;399-405.
102. Wagner H., Richert R. Spatial Uniformity of the beta-Relaxation in D-sorbitol. J. Non-Crystalline Sol. 242:1998;19-24.
103. Hikima T., Hanaya M., Oguni M. Microscopic observation of a peculiar crystallization in the glass transition region and beta-process as potentially controlling the growth rate in triphenylethylene. J. Mol. Structure. 479:1999;245-250.
104. Fox T.G. Influence of diluent and of copolymer composition on the glass transition temperature of a polymer system. Bull. Am. Phys. Soc. Ser. II. 1:1956;123.
105. Couchman P.R. The composition-dependent glass transition: relations between temperature, pressure, and composition. Polymer Eng. and Sci. 24:1984;135.
106. Gordon M., Taylor J.S. Ideal copolymers and the second-order transitions of synthetic rubbers. i. non-crystalline copolymers. J. Appl. Chem. 2:1952;493.
107. Hancock B.C., Zografi G. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. 11:1994;471-477.
108. Matsumoto T., Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm. Res. 11:1999;1722-1728.
109. Shalaev E.Y., Zografi G. How does residual water affect the solid-state degradation of drugs in the amorphous state. J. Pharm. Sci. 85:1996;1137-1141.
110. Lai M.C., Topp E.M. Solid-state chemical stability of proteins and peptides. J. Pharm. Sci. 88:1999;489-500.
111. Sun W.Q., Davidson P., Chan H.S.O. Protein stability in the amorphous carbohydrate matrix: relavance to anhydrobiosis. Biochim. Biophys. Acta. 1425:1998;245-254.
112. Hatley R.H.M., Blair J.A. Stabilization and delivery of labile materials by amorphous carbohydrates and their derivatives. J. Mol. Catalysis B: Enzymatic. 7:1999;11-19.
113. Bernstein J. Conformational polymorphism. Desiraju G.R. Organic Solid State Chemistry. 1987;Elsevier, Amsterdam.
114. Shalaev E.Y., Lu Q., Shalaeva M. G. Zografi Acid-catalyzed inversion of sucrose in the amorphous state at very low levels of residual water. Pharm. Res. 17:2000;366-370.
115. Yoshioka M., Hancock B.C., Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83:1994;1700-1705.
116. Hatley R.H.M. Glass fragility and the stability of pharmaceutical preparations - excipients selection. Pharm. Dev. Technol. 2:1997;257-264.
117. Crowe L.M., Reid D.S., Crowe J.H. Is trehalose special for preserving dry biomolecules? Biophys. J. 71:1996;2087-2093.
118. Magazu S., Maisano G., Migliardo P., Tettamanti E., Villari V. Transport phenomena and anomalous glass-forming behavior in alpha, alpha-trehalose aqueous solutions. Mol. Phys. 96:1999;381-387.
119. Branca C., Magazu S., Maisano G., Migliardo P. Anomalous cryoprotective effectiveness of trehalose: Raman scattering evidence. J. Chem. Phys. 111:1999;281-287.